Fermenta Biotech [FERMENTA] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Fermenta Biotech Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Fermenta Biotech Ltd. wins in 8 metrics, Sun Pharmaceutical Industries Ltd. wins in 12 metrics, with 0 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Fermenta Biotech Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 10.85 36.73 Fermenta Biotech Ltd.
Price-to-Book Ratio 2.40 5.15 Fermenta Biotech Ltd.
Debt-to-Equity Ratio 29.03 6.68 Sun Pharmaceutical Industries Ltd.
PEG Ratio -0.17 3.59 Sun Pharmaceutical Industries Ltd.
EV/EBITDA 8.13 23.61 Fermenta Biotech Ltd.
Profit Margin (TTM) 16.00% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) 14.26% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 14.26% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity 21.44% 15.08% Fermenta Biotech Ltd.
Return on Assets (TTM) 12.51% 11.87% Fermenta Biotech Ltd.
Free Cash Flow (TTM) $187.69M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield 0.71% 0.97% Sun Pharmaceutical Industries Ltd.
1-Year Return -5.37% 7.25% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 1.71 7.05 Fermenta Biotech Ltd.
Enterprise Value $9.90B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 1.82 6.66 Fermenta Biotech Ltd.
Gross Profit Margin (TTM) 62.42% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $186 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $29.63 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) -0.13 0.11 Fermenta Biotech Ltd.

Fermenta Biotech Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

FERMENTA
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fermenta Biotech Ltd.0.80%8.12%5.90%0.46%17.65%-9.36%
Sun Pharmaceutical Industries Ltd.-0.47%-3.03%-1.92%2.17%-1.01%3.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fermenta Biotech Ltd.-5.37%110.03%-8.87%55.86%55.86%55.86%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: Fermenta Biotech Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricFERMENTASUNPHARMA
Market Information
Market Cap i₹9.28B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i14,0403,903,142
90 Day Avg. Volume i18,7963,253,866
Last Close₹319.55₹1,780.10
52 Week Range₹256.40 - ₹399.00₹1,548.00 - ₹1,916.60
% from 52W High-19.91%-7.12%
All-Time High₹449.00 (Feb 10, 2025)₹1,960.35 (Sep 30, 2024)
% from All-Time High-28.83%-9.19%
Growth Metrics
Quarterly Revenue Growth-0.12%0.14%
Quarterly Earnings Growth-0.66%0.16%
Financial Health
Profit Margin (TTM) i0.16%0.19%
Operating Margin (TTM) i0.14%0.26%
Return on Equity (TTM) i0.21%0.15%
Debt to Equity (MRQ) i29.036.68
Cash & Liquidity
Book Value per Share (MRQ)₹134.13₹324.46
Cash per Share (MRQ)₹17.83₹115.87
Operating Cash Flow (TTM) i₹-59,490,000₹110.84B
Levered Free Cash Flow (TTM) i₹768.62M₹109.29B
Dividends
Last 12-Month Dividend Yield i0.71%0.97%
Last 12-Month Dividend i₹2.50₹16.50

Valuation & Enterprise Metrics Analysis: Fermenta Biotech Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricFERMENTA (Apr 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i10.8536.73
Forward P/E iN/A29.48
PEG Ratio i-0.173.59
Price to Sales (TTM) i1.717.05
Price to Book (MRQ) i2.405.15
Market Capitalization
Market Capitalization i₹9.28B₹3.88T
Enterprise Value i₹9.90B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i1.826.66
Enterprise to EBITDA i8.1323.61
Risk & Other Metrics
Beta i-0.130.11
Book Value per Share (MRQ) i₹134.13₹324.46

Financial Statements Comparison: Fermenta Biotech Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricFERMENTA (2025)SUNPHARMA (2025)
Revenue/Sales i4.67B520.41B
Cost of Goods Sold i1.63B121.98B
COGS % of Revenue i35.0%23.4%
Gross Profit i3.04B398.44B
Gross Margin i65.0%76.6%
Research & Development iN/AN/A
Operating Income (EBIT) i933.53M125.81B
Operating Margin i20.0%24.2%
EBITDA i1.24B167.25B
EBITDA Margin i26.6%32.1%
Pre-Tax Income i832.08M137.52B
Pre-Tax Income % of Revenue i17.8%26.4%
Income Tax i68.05M27.72B
Income Tax % of Revenue i1.5%5.3%
Net Income (Profit) i764.03M109.65B
Profit Margin i16.4%21.1%

Balance Sheet & Liquidity Metrics

MetricFERMENTA (2025)SUNPHARMA (2025)
Cash & Equivalents i282.40M102.69B
Total Current Assets i3.35B526.24B
Total Current Assets % of Revenue i71.8%101.1%
Total Current Liabilities i2.12B181.94B
Total Current Liabilities % of Revenue i45.4%35.0%
Long-Term Debt i194.91M3.58B
Long-Term Debt % of Revenue i4.2%0.7%
Total Shareholders Equity i3.59B724.86B
Retained Earnings i3.25B578.62B
Retained Earnings % of Revenue i69.7%111.2%
Property, Plant & Equipment i2.16B100.36B

Cash Flow Statement Comparison

MetricFERMENTA (2025)SUNPHARMA (2025)
Operating Cash Flow i-59.49M110.84B
Operating Cash Flow % of Revenue i-1.3%21.3%
Capital Expenditures i-28.82M-20.68B
Free Cash Flow i187.69M119.44B
FCF Margin i4.0%23.0%
Debt Repayment i-358.24M-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricFERMENTASUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i28.87M2.40B
Float Shares i8.42M1.07B
% Held by Insiders i71.66%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i28.34%15.69%

Dividend Analysis & Yield Comparison: Fermenta Biotech Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricFERMENTASUNPHARMA
Last 12-Month Dividend i₹2.50₹16.50
Last 12-Month Dividend Yield i0.71%0.97%
3-Year Avg Annual Dividend i₹0.83₹17.33
3-Year Avg Dividend Yield i0.71%0.51%
3-Year Total Dividends i₹2.50₹52.00
Ex-Dividend DateAug 06, 2025Feb 05, 2026